- Home
- App-Analyse
- Pinkypromise-Alnoor
- Pinkypromise-Alnoor Vs. Breast Cancer Survivorship
Pinkypromise-Alnoor im Vergleich zu Breast Cancer Survivorship Nutzung und Statistiken
Simple app for Breast self examination to prevent Breast Cancer.
- Apple App Store
- Kostenlos
- Gesundheit und Fitness
Rang speichern
- -
About Us
“Thrive HKU” is an initiative mobile application of The Department of Clinical Oncology, LKS Faculty of Medicine of the University of Hong Kong. “Thrive HKU” aims to provides better support for breast cancer survivors both physically and psychologically.
“Thrive HKU” equips breast cancer survivors with educational materials on breast cancer management and psychological support. Registered users will be given a Pink Fitbit which can encourage them to have more exercises and have a healthy lifestyle.
We wish breast cancer survivors who use the thrive app and Pink Fitbit every day can have a bright and healthy future!
Disclaimer
The information contained in this App is for general educational purpose and reference only. Such information is not medical advice, diagnosis or treatment on any individual case or patient and should not be treated as a substitute for professional medical advice, diagnosis or treatment. You should consult your attending doctor or health professional for any medical condition that you may have, rather than relying on the information provided in this App.
- Apple App Store
- Kostenlos
- Gesundheit und Fitness
Rang speichern
- -
Pinkypromise-Alnoorvs. Breast Cancer Survivorship Ranking-Vergleich
Vergleichen Sie Pinkypromise-Alnoor den Ranking-Trend der letzten 28 Tage mit Breast Cancer Survivorship
Rang
Keine Daten verfügbar
Pinkypromise-Alnoor im Vergleich zu Breast Cancer Survivorship Ranking im Ländervergleich
Vergleichen Sie Pinkypromise-Alnoor den Ranking-Trend der letzten 28 Tage mit Breast Cancer Survivorship
Keine Daten zum Anzeigen
Stellen Sie mit unserer kostenlosen Testversion Vergleiche mit jeder Website an
Pinkypromise-Alnoor VS.
Breast Cancer Survivorship
Dezember 31, 2024